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The congenital long QT syndrome (LQTS) is a cardiac electrophysiological disorder that
can cause sudden cardiac death. LQT1 is a subtype of LQTS caused by mutations in
KCNQ1, affecting the slow delayed-rectifier potassium current (IKs), which is essential
for cardiac repolarization. Paradoxically, gain-of-function mutations in KCNQ1 have been
reported to cause borderline QT prolongation, atrial fibrillation (AF), sinus bradycardia,
and sudden death, however, the mechanisms are not well understood. The goal of
the study is to investigate the ionic, cellular and tissue mechanisms underlying the
complex phenotype of a gain-of-function mutation in KCNQ1, c.686G > A (p.G229D)
using computer modeling and simulations informed by in vitro measurements. Previous
studies have shown this mutation to cause AF and borderline QT prolongation.
We report a clinical description of a family that carry this mutation and that a
member of the family died suddenly during sleep at 21 years old. Using patch-clamp
experiments, we confirm that KCNQ1-G229D causes a significant gain in channel
function. We introduce the effect of the mutation in populations of atrial, ventricular
and sinus node (SN) cell models to investigate mechanisms underlying phenotypic
variability. In a population of human atrial and ventricular cell models and tissue, the
presence of KCNQ1-G229D predominantly shortens atrial action potential duration
(APD). However, in a subset of models, KCNQ1-G229D can act to prolong ventricular
APD by up to 7% (19 ms) and underlie depolarization abnormalities, which could
promote QT prolongation and conduction delays. Interestingly, APD prolongations were
predominantly seen at slow pacing cycle lengths (CL > 1,000 ms), which suggests a
greater arrhythmic risk during bradycardia, and is consistent with the observed sudden
death during sleep. In a population of human SN cell models, the KCNQ1-G229D
mutation results in slow/abnormal sinus rhythm, and we identify that a stronger L-type
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calcium current enables the SN to be more robust to the mutation. In conclusion,
our computational modeling experiments provide novel mechanistic explanations for
the observed borderline QT prolongation, and predict that KCNQ1-G229D could
underlie SN dysfunction and conduction delays. The mechanisms revealed in the
study can potentially inform management and treatment of KCNQ1 gain-of-function
mutation carriers.
Keywords: KCNQ1, long QT syndrome, gain-of-function, arrhythmia, sinus node, computational biology
INTRODUCTION
Long QT Syndrome (LQTS) is a type of cardiac disorder that is
often related to syncope and sudden cardiac death. LQT1, which
is the most common form of LQTS, is caused by mutations in
the KCNQ1 gene, affecting the slow delayed-rectifier repolarizing
current (IKs) (Barhanin et al., 1996; Sanguinetti et al., 1996). Loss-
of-function mutations in KCNQ1 can reduce IKs and underlie the
inherited form of long QT syndrome (LQT1) (Wang et al., 1996),
while gain-of-function mutations in KCNQ1 can act to increase
channel opening, resulting in enhanced IKs (Chen et al., 2003;
Hong et al., 2005; Lundby et al., 2007; Das et al., 2009; Bartos et al.,
2011, 2013; Ki et al., 2014; Moreno et al., 2015).
Gain-of-function mutations in KCNQ1 associate with
complex phenotypes. To date, eight gain-of-function mutations
in KCNQ1 have been identified that underlie persistent familial
atrial fibrillation (AF) (Hancox et al., 2014; Hasegawa et al.,
2014), and four have been reported to cause short QT syndrome
type 2 (SQT2) (Bellocq et al., 2004; Hong et al., 2005; Moreno
et al., 2015; Wu et al., 2015). Some of these gain-of-function
mutations are additionally associated with sinus bradycardia
[S140G (Chen et al., 2003), V141M (Hong et al., 2005), R231C
(Henrion et al., 2012), V241F (Ki et al., 2014), and F279I (Moreno
et al., 2015)], and paradoxically, some KCNQ1 gain-of-function
mutations have been linked to QT prolongation (borderline
LQT) [S140G (Chen et al., 2003), Q147R (Lundby et al., 2007),
R231C (Bartos et al., 2011; Henrion et al., 2012) and R231H
(Bartos et al., 2013)]. The mechanisms underlying how certain
KCNQ1 gain-of-function mutations cause AF and SQT2 have
been revealed by in silico studies. In general, the gain in IKs
function acts to shorten the refractory period and stabilize
re-entrant waves, therefore promoting AF and ventricular
arrhythmia (Kharche et al., 2012; Zulfa et al., 2016; Adeniran
et al., 2017). In addition, the effects of several gain-of-function
KCNQ1 mutations (V141M, R231C, and V241F) on sinus
bradycardia have recently been explored using human in silico
models of the sinus node (SN) (Fabbri et al., 2017; Whittaker
et al., 2018). However, the mechanisms that underlie why
certain KCNQ1 gain-of-function mutations are associated with
borderline LQT and the factors that may explain phenotypic
variability remain unclear.
The goal of this study is to investigate the ionic, cellular
and tissue mechanisms underlying the complex phenotype of a
gain-of-function mutation in KCNQ1, p.G229D (c.686G > A),
(KCNQ1-G229D) using human atrial, ventricular and SN models
informed by in vitro patch-clamp measurements. This mutation
was first reported in 2014 in a 16-year-old boy with AF (Hasegawa
et al., 2014). Interestingly, after radiofrequency catheter ablation
therapy sinus rhythm was maintained, but the boy represented
with borderline LQT (Hasegawa et al., 2014). Here, we report the
clinical features of members of a British family affected by the
same mutation. In addition to AF and borderline LQT, sudden
death also happened in this family. By using a population of
models approach, we investigate how natural variations in ionic
current density could underlie variability in the phenotype of
mutation carriers. In particular, we focus on the mechanisms
that underlie the associated borderline LQT, which has also been
reported for other KCNQ1 gain-of-function mutations but has
not been explored. In addition, we investigate potential effects on
the SN, based on the SN dysfunction caused by other KCNQ1
gain-of-function mutations.
MATERIALS AND METHODS
Clinical Data and QT Interval Duration
Assessment
The clinical characterisation of the family carrying the
G229D mutation was carried out in accordance with the
recommendations of the National Health Service (NHS) Health
Research Authority. The protocol was approved by the National
Research Ethics Service (NRES Committee) East Midlands -
Nottingham 2 [Research Ethics Committee (REC) reference:
09/H0508/74]. All subjects gave written informed consent
in accordance with the Declaration of Helsinki. QT interval
duration was measured on resting electrocardiograms (ECGs)
using lead V5 or II (Figure 1). In patients in sinus rhythm an
average of three consecutive beats was calculated. In patients
with AF an average of six consecutive beats was calculated. The
Bazett formula (Bazett, 1920) was used to correct QT according
to heart rate (QTc).
Molecular Biology and Cell Culture
We characterized the effects of the G229D mutation on
KCNQ1/KCNE1 (IKs) channel function by whole-cell patch-
clamp in a heterologous expression system [Chinese Hamster
Ovary-K1 (CHO-K1) cells]. KCNQ1 (GenBank R© accession
number AF000571) and KCNE1 are as described in Harmer
et al. (2014). pEGFP-N1 was from Clontech. The patient-
identified G229D mutation (c.686G > A) was introduced into
KCNQ1 using site-directed mutagenesis [Quikchange II XL
(Agilent Technologies)].
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CHO-K1 cells (Sigma-Aldrich, 85051005) were cultured as
described in Harmer et al. (2014). To analyze the effects
of G229D, cells were transfected with 250 ng of wild-type
(WT) KCNQ1 or LQT1 mutant cDNA and 500 ng of KCNE1
(+50 ng pEGFP-N1) (IKs-WT or IKs-G229D, respectively). To
mimic the heterozygous patient phenotype (IKs-HET), cells were
transfected with 125 ng of wild-type channel+ 125 ng of mutant
channel and 500 ng KCNE1 (+50 ng pEGFP-N1). Transfections
were performed as described in Harmer et al. (2014). After
transfection, cells were split at low density onto 10 mm glass
coverslips and transfected cells (identified by fluorescence) were
patched 48 h later.
Patch-Clamp Electrophysiological
Recording and Analysis
Whole-cell currents were recorded using an Axopatch 200B
amplifier (Axon Instruments/Molecular Devices). Data
acquisition was performed using pCLAMP10 software through
a Digidata 1440A (Axon Instruments/Molecular Devices). Data
digitization (sampling) rates were 0.5 kHz and recordings were
lowpass Bessel filtered at 1 kHz.
Whole-Cell Patch-Clamp
For the experiments detailed in Figure 2 whole-cell patch-
clamp recording was performed at room temperature (22◦C) as
described in Thomas et al. (2011). The intracellular (pipette)
solution contained: (mmol/L) 150 KCl, 10 HEPES, 5 EGTA,
2 MgCl2, 1 CaCl2 and 5 (Na)2ATP (pH 7.2 with KOH). The
extracellular (bath) solution contained: (mmol/L) 150 NaCl, 5
KCl, 10 HEPES, 2 MgCl2, and 1 CaCl2 (pH 7.4 with NaOH).
Pipette resistances were, once filled with intracellular solution,
between 2 and 3 mega-ohms (M). Pipette capacitance was
reduced by coating the pipette tip with SigmaCote (SL2, Sigma).
Once the whole-cell configuration had been achieved cells were
dialyzed for 2 min before recording. Series resistance (Rseries) was
compensated by at least 70% using the amplifier circuitry. The
liquid junction potential [calculated using the Junction Potential
tool in pCLAMP (Axon Instruments/Molecular Devices)]
was relatively small (+4.3 mV) and therefore post-recording
adjustments of membrane potential were not performed. The
voltage protocol used is outlined in Figure 2 and the cycle length
for this protocol was 0.1 Hz.
Patch-Clamp Recording Analysis
Data were analyzed using Clampfit (Molecular Devices) and
GraphPad Prism. As previously described in Thomas et al. (2011)
current-voltage relationships were generated by normalizing the
maximal current densities at the end of each pulse-potential
to cell capacitance. Peak-tail current density (PTCD) was
analyzed by normalizing the peak tail currents (in response
to the prior test potential) to cell capacitance. The voltage-
dependence of channel activation (or steady-state of activation)
was determined by fitting the normalized peak tail current
amplitudes (y/ymax) versus a test potential (V t) with a Boltzmann
function [y/ymax = 1/(1 + exp[(V0.5 − V t)/k])] (k indicates the
slope factor). The V0.5 value indicates the potential at which
channel activation is half-maximal.
Computational Modeling of the Effects of
the G229D Mutation on KCNQ1/KCNE1
Channel Function
The IKs formulation from the human ventricular O’Hara-Rudy
dynamic model (ORd) model (O’Hara et al., 2011) was used
to replicate the patch-clamp data (Supplementary Material).
Least square curve fitting (lsqcurvefit) was combined with
the Multi-Start algorithm in Matlab to find the parameters
with optimized fitting results for the mutated IKs. Additional
fitting details including model formulation are presented in
the Supplementary Material. The optimized fitting results
for IKs-HET (KCNQ1 + G229D + KCNE1) and IKs-G229D
(G229D + KCNE1) were inserted into the IKs current
formulation of the ORd model, the human atrial (Grandi et al.,
2011) and (Maleckar et al., 2009) and Fabbri human SN models
(Fabbri et al., 2017).
To test whether the effects of our IKs-HET formulation on
action potential duration (APD) and SN were stable, we also
used the IKs/IKs-HET formulations of Hasegawa et al. (2014) to
check the robustness of our results. Action Potential (AP) clamp
simulations using three AP traces with different plateau levels
were used to examine whether the effect of AP plateau on rapid
delayed rectifier potassium current (IKr) was model specific by
comparing the ORd, Maleckar, and Grandi models.
In silico Populations of Human
Ventricular Cell and One-Dimensional
(1D) Tissue Fibers Models
A population of 2326 ORd-derived models calibrated with
human in vivo data was used to account for the effect of
human electrophysiological variability as in Zhou et al. (2016).
An initial population of 10,000 models was constructed by
varying the main ionic conductances by up to ±100% using
Latin Hypercube Sampling, including fast sodium current
conductance (GNa), late sodium current conductance (GNaL),
transient outward potassium current conductance (Gto),
L-type calcium current conductance (GCaL), rapid delayed
rectifier potassium current conductance (GKr), slow delayed
rectifier potassium current conductance (GKs), inward rectifier
potassium current conductance (GK1), sodium-potassium
pump current conductance (GNaK), sodium-calcium exchange
current conductance (GNaCa), sarcoplasmic reticulum (SR)
calcium release permeability (PJrel) and SR calcium re-uptake
permeability (PJup). The initial population of 10,000 models was
calibrated using the human in vivo measurements described in
Zhou et al. (2016). The advantage of using a population of models
rather than just a standard baseline model is that it provides
scenarios of natural variability (Muszkiewicz et al., 2016), in
particular for investigations on multiple disease phenotypes and
variable penetrance (Passini et al., 2016).
In the ORd model, the level of GKs is greatest in epicardial
cells. Therefore, in order to evaluate the strongest possible effects
in ventricles, we simulated the effect of the KCNQ1-G229D
mutation in epicardial fibers. A population of monodomain
homogeneous epicardial 1D fibers of 2 cm was derived from the
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ORd single cell population. Pseudo-ECG signals were computed
as the integral of spatial gradient of transmembrane potentials
from all the points in the fibers (Gima and Rudy, 2002). The tissue
simulations and pseudo-ECG calculations were conducted in the
open-source software CHASTE (Pitt-Francis et al., 2009) for 50
beats with a conductivity of 3.92 mS/cm to obtain a conduction
velocity of 69 cm/s in the baseline ORd epicardial fiber.
Transmural fibers consisting of 80% of endocardial cells and 20%
of epicardial cells were also simulated for some representative
cases with a conductivity of 1.19 mS/cm to obtain a transmural
conduction velocity of 40 cm/s in the baseline ORd model.
Construction and Calibration of Human
Atrial Cell Population of Models
Using a similar methodology as in Britton et al. (2013), the nine
current conductances of the Grandi atrial cell models (Grandi
et al., 2011) were varied by up to ±100% using Latin Hypercube
Sampling to generate an initial candidate population of 5,000
models: GNa, GNaL, Gto, GCaL, GKr, GKs, GK1, ultrarapid delayed
rectifier potassium current conductance (GKur), GNaK, and GNaCa.
These currents were chosen based on their direct contributions to
the regulation of APDs, and intracellular calcium fluxes were not
varied due to their relatively small effects on APD (Muszkiewicz
et al., 2018). After pacing each model under CL = 1,000 ms for 500
beats, the experimental biomarker ranges from human atrial cells
were used to select the models in range with the experimental
data reported in Sanchez et al. (2014). The models accepted
under cycle length (CL) = 1,000 ms were then paced under
CL = 2,000 ms and CL = 500 ms. The 917 models that did not
display delayed afterdepolarizations, early afterdepolarizations
or depolarization failure under all three CLs were accepted for
further analysis.
Construction and Calibration of Human
Sinus Node Cell Population of Models
An initial population of 5,000 models was generated from the
baseline Fabbri model (Fabbri et al., 2017) by using Latin
hypercube sampling to introduce up to ±100% variations to 12
current conductances and ion flux magnitudes: funny current
conductance (Gf), GCaL, T-type calcium current conductance
(GCaT), GKr, GKs, Gto, GNa, GNaK, GNaCa, GKur, PJrel, and PJup.
These currents were chosen because both sarcolemmal currents
and calcium handling affect spontaneous depolarization. After
simulating each model for 1,000 s, 1046 models with a basic
cycle length between 600 and 1,000 ms (heart rate between 60
and 100 bpm) and a positive overshoot membrane potential were
accepted for further analysis. The effects of IKs-HET in human
SN models were classified into three categories: Robust (heart
rate between 60 and 100 bpm and a positive overshoot potential),
Bradycardia (a positive overshoot potential and heart rate slower
than 60 bpm), and Pacemaking failure (a negative maximum
potential or a loss of spontaneous activity).
Statistical Analysis
Patch-clamp experimental data was compared/analyzed using
a one-way ANOVA with Bonferroni post hoc test for multiple
comparisons. Patch-clamp data was considered significantly
different if P < 0.05. Statistical analysis of in silico modeling was
conducted with Wilcoxon rank-sum test using Matlab, using a
standard P < 0.05, and differences in current conductances are
reported in the figures and visualized as the differences of the
medians of the distributions.
RESULTS
Clinical Description of KCNQ1-G229D
Mutation Carriers
Patient A was seen after her daughter (Patient C) died
unexpectedly whilst sleeping at 21 years of age (Figure 1A).
Patient A reported that as a teenager she had occasional periods
of fainting but no reported exertional syncope. Her ECG was
in sinus rhythm at 68 bpm (Figures 1B,C) and her QTc was
465 ms. It was noted following an ectopic beat that her QTc
prolonged to 490 ms.
On the basis of the borderline QT prolongation and the death
of her daughter she was genetically tested. Genetic testing found
a previously reported pathogenic variant in KCNQ1 c.686G > A
(p.G229D) (Hasegawa et al., 2014). Based on this finding, other
members of the family were genetically screened. Screening
revealed that her mother (Patient B) and granddaughter (Patient
D) are carriers of the KCNQ1 c.686G > A (p.G229D) mutation.
Genetic testing for Patient C was not performed during autopsy
but her relationship in the family proves that she was an obligate
carrier. Clinical details for Patient D are unavailable. Patient B
was first diagnosed with AF at 60 years of age and does not have
a history of syncope. Her QTc values, measured in the presence
of AF, were 440–446 ms (Figure 1C). Our clinical data, and
that reported by (Hasegawa et al., 2014) and (Moreton et al.,
2013), indicate that KCNQ1 c.686G > A (p.G229D) has high
penetrance and that it is associated with AF, borderline LQT and
sudden cardiac death.
Effect of the G229D Mutation on IKs
Channel Function in vitro and in silico
Patch clamp measurements show that G229D co-expression
with KCNE1 (IKs-G229D) produced currents with marked
instantaneous activation and tail currents that failed to deactivate
(Figure 2A). To mimic the patient phenotype KCNQ1 and
G229D were co-expressed (with KCNE1) in heterozygous form
(IKs-HET). The currents produced by IKs-HET possessed both
instantaneous and slow activation components reflecting a
combined phenotype (Figure 2A) and the presence of G229D
acted to shift the voltage-dependence of channel activation (V0.5)
by approximately−35 mV (Figure 2D).
Overall, our observed effects of G229D on channel function
correlate well with the gain-of-function effect first reported
by (Hasegawa et al., 2014). Using the electrophysiological data
from the patch-clamp studies, we then modeled in silico the
effects of the G229D mutation on channel function. The fitting
details for IKs-G229D and IKs-HET are shown in Supplementary
Figures S1–S3. The resulting IKs-G229D and IKs-HET models
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FIGURE 1 | Partial pedigree and clinical information for members of a family carrying the KCNQ1 mutation G229D (c.686G>A). (A) Partial mini pedigree of a British
family that present with a complex arrhythmic phenotype that includes sudden cardiac death (SCD), atrial fibrillation (AF), and borderline QT prolongation. Circles
indicate female family members. (B) Lead II and V5 electrocardiograms (ECGs) from Patient (A) with borderline QT prolongation but not AF. (C) Clinical characteristics
of carriers of the KCNQ1-G229D mutation. ∗ = Not genetically tested but obligate carrier of the KCNQ1-G229D mutation (c.686G>A) based on position in the family.
Please refer to (A) for the location of each patient in the pedigree. NK, not known; NA, not available.
were then incorporated into the populations of human atrial,
ventricular and sino-atrial cell models to investigate the complex
electrophysiological consequences of the mutation.
The Predominant Effect of IKs
Gain-of-Function G229D Mutation Is APD
Shortening in Both the Atria and Ventricle
In the baseline human atrial Grandi model, IKs-HET caused
significant reductions in APD (14.22%) and weakened the AP
upstroke (Figure 3A), in agreement with (Hasegawa et al., 2014).
Similarly, in the baseline ventricular ORd model, the presence
of IKs-HET also weakened the AP upstroke and led to AP
shortening by 9.83%. Both APD shortenings occurred because
IKs-HET produced a much stronger current during the whole
AP, and therefore repolarization proceeded more quickly. The
degree of shortening in the Grandi atrial model was greater
than in the ventricular model (Figures 3A,B), and even greater
shortening of APD was seen in the Maleckar human atrial
model (33.23% reduction, Supplementary Figure S4). Therefore,
the more significant APD shortening observed in human atrial
models is not model-dependent.
We investigated potential variability in the effect of IKs-
HET formulations when inserted in populations of human
ventricular and atrial models with variable ionic profiles. As
an accumulation of IKs during increases in heart rate may
be important for repolarization (Viswanathan et al., 1999), we
applied both slow and fast pacing CLs (2,000, 1,000, 500, and
333 ms). For both populations of models, the most common
effect of the mutation was APD shortening (Supplementary
Figure S5 and Figures 3C,D). Under CL = 1,000 ms, the median
APD shortening in the human ventricular cell population was
22 ms, while in the human atrial cell population, the median
shortening was 29 ms (Figures 3C,D). Thus, when considering
ionic variability in the population, the G229D mutation induced
greater APD shortening in human atria than in the ventricular
models. Since the baseline Maleckar atrial model already showed
an even greater APD shortening than the Grandi atrial model
under the mutation, we did not construct a population of
Maleckar atrial models to verify this phenomenon. Further
analysis showed that the conductances of IKr, IKs, and ICaL
were the main determinants for the extent of ventricular APD
shortening caused by IKs-HET (Figure 3E). Models with weak
GCaL and GKr and strong GKs tended to present with more
significant APD shortening under IKs-HET (Figure 3F). In
the atrial population of models, a greater number of currents
played roles in the regulation of APD shortening, and the
most important factor was GKs (Figure 3E). Stronger GKs,
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FIGURE 2 | KCNQ1-G229D dramatically alters the biophysical properties of the KCNQ1/KCNE1 (IKs) channel. (A) Representative traces of the currents produced by
wild-type (WT) KCNQ1 (KCNQ1 + KCNE1: IKs-WT) or G229D when expressed homozygously (G229D + KCNE1: IKs-G229D) or in heterozygous fashion
(KCNQ1 + G229D + KCNE1: IKs-HET). The effect of the G229D mutation on channel function, in CHO-K1 cells, was analyzed by whole-cell patch-clamp. In all
cases, to recapitulate the IKs current, KCNE1 was co-expressed. The zero-current level (0 pA) is indicated by the gray line. The voltage protocol used to elicit these
currents is inset in (A). (B) Mean current-voltage relationships (current density). (C) Peak-tail current density (PTCD). (D) Normalized voltage-dependent activation
curves (V0.5) (in mV). The activation curves are fit with Boltzmann functions (solid lines). (E) Black and gray arrows indicate the points where the current density
signals [current density (CD)] and PTCD were used to calculate the corresponding biomarkers for analysis and fitting. Data are presented as mean ± SEM.
(n = 8–12). N.D., not determined. ∗ indicates significantly different from WT control value (P < 0.05) (One-way ANOVA analysis with Bonferroni post hoc test).
GNaK, and GCaL, and weaker GK1, Gto, GKur, and GKr were
associated with more significant APD shortening in the atrial
cells (Figure 3E).
Borderline APD Prolongation May Occur
Due to the Interplay Between IKr and
IKs-HET
Although APD shortening was consistently observed under four
pacing CLs (Supplementary Figure S5), some human ventricular
models in the population resulted in APD prolongation in
the presence of IKs-HET, especially at slower pacing rates
(Figure 4A). Furthermore, the number of ventricular cell models
that showed obvious APD prolongation (>5 ms) was also
increased as pacing rates became slower (no models under
CL = 500/333 ms, 5 models under CL = 1,000 ms and 25
models under CL = 2,000 ms). Therefore, in the presence
of KCNQ1-G229D, APD prolongation occurred more often at
slower pacing rates.
There was no significant difference between the WT APDs
between the prolongation models and other models in the
population. However, the AP peak membrane voltage was
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FIGURE 3 | In silico simulations of the effects of KCNQ1-G229D on human ventricular and atrial action potentials. The effect of the G229D mutation on membrane
voltage (Vm, mV, insets showing peak upstroke) and IKs (µA/µF) in the Grandi human atrial cell model (A) and the ORd human ventricular epicardial cell model (B).
Comparison of absolute APD change (1APD = APD-IKs-HET – APD-IKs-WT, C) and relative APD change (1APD/APD-IKs-WT, D) after introducing IKs-HET between
Grandi atrial population of models and ORd ventricular population of models at CL = 1,000 ms (∗∗∗P < 0.001) (Wilcoxon rank-sum test). (E) Partial correlation
analysis between 1APD at CL = 1,000 ms and current conductances in the population of atrial and ventricular models. The partial correlation coefficients (PCC) are
indicated by the color scale, where red implies a strong positive correlation and blue implies a strong negative correlation. (F) Relationship between the
conductances of IKr, IKs, and ICaL and the 1APD in the ORd population. 0–2 represent the scaling factors for the baseline conductances in the ±100% range.
significantly reduced (Figure 4B) due to smaller baseline
depolarization current conductances (GNa and GCaL) in the
models displaying APD prolongation (Figure 4C). In addition,
stronger baseline GKr was found in the models displaying
APD prolongation at CL = 1,000 or 2,000 ms (Figure 4C).
In the subgroup of models producing APD prolongation
at CL = 1,000 ms, replacing our IKs/IKs-HET formulations
with the IKs/IKs-HET formulations of Hasegawa et al. (2014)
also generated consistent APD prolongation, supporting the
robustness of these phenomena (Supplementary Figure S6).
To understand the ionic mechanisms underlying APD
prolongation/shortening, we analyzed the change of individual
currents induced by the presence of the G229D mutation. The
biggest differences in ionic currents for both prolongation and
shortening were the increase of IKs (Figures 5A,B, middle panels)
and the secondary decrease of IKr (Figures 5A,B, right panels).
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FIGURE 4 | KCNQ1-G229D can lead to ventricular APD prolongation at slow
pacing rates. (A) APD prolongations under four pacing rates
(1APD = APD-IKs-HET – APD-IKs-WT). (B) Comparison of the WT peak
membrane voltage between the models that showed or did not show APD
prolongation under IKs-HET at CL = 1,000 ms. (C) Parameter comparison
between models that showed APD prolongation at CL = 1,000 or 2,000 ms
and those that did not show APD prolongation under IKs-HET. The y-axis
represents the scaling factors in the ±100% range (0–2) to the original
baseline ORd model current conductances (∗∗∗P < 0.001) (Wilcoxon
rank-sum test). Black points indicate extreme values that lie more than 1.5
times the interquartile range away from the top (the 75th percentile) or bottom
(the 25th percentile) of the box.
We selected two representative ventricular cell models with
similar AP upstroke but one displaying shortening and the other
prolongation with IKs-HET. The presence of IKs-HET affected the
AP upstroke and led to a smaller peak membrane voltage and a
lower plateau in both models. The reduction in IKr magnitude
after G229D introduction was likely due to the reduced phase 2
AP plateau (Figures 5A,B, left panels).
To verify whether this was model-specific, we conducted AP
clamp simulations using different human IKr models. The IKr
magnitude was consistently weaker under a smaller phase 2
AP plateau in all models tested (Supplementary Figure S7).
For the human ventricular model displaying APD prolongation
with IKs-HET, the decrease of IKr amplitude was slightly bigger
than the increase of IKs amplitude under the IKs-HET condition
(Figure 5A, middle and right panels). In contrast, in the human
ventricular model displaying APD shortening, the augmentation
of IKs was more significant than the inhibition of IKr (Figure 5B,
middle and right panels).
Therefore, our explanation was that if the inhibition of IKr
can overcome the augmentation of IKs, the presence of the
G229D mutation could lead to an overall weaker repolarization,
and therefore a prolonged APD. Importantly, the prolongation
models tended to have stronger IKr (Figure 4C), which was
crucial for IKr reduction to be dominant under IKs-HET. We
also noticed that under slow pacing, the magnitude of IKs
decreased, whereas IKr increased (Supplementary Figure S8),
which explained the increased number of models with APD
prolongation at slow pacing. Overall, these findings further
highlight that in the presence of the G229D mutation, ventricular
APD prolongation is more likely to occur during bradycardia,
particularly for strong IKr models.
By Counteracting Action Potential
Upstroke Dynamics KCNQ1-G229D
Could Promote Tissue Conduction
Abnormalities
As illustrated earlier, the G229D mutation can reduce peak
AP membrane voltage. We hypothesized that IKs-HET by
counteracting AP upstroke dynamics (Figures 3A,B, 5A,B)
could have important effects on the safety of conduction. In
addition, we need to confirm whether the ionic mechanisms
underlying APD prolongation in single cells hold true at the tissue
level. Therefore, we investigated conduction and repolarization
patterns in the presence of IKs-HET on the population of human
ventricular one-dimensional (1D) fibers.
The original ventricular 1D fiber showed a shorter QT interval
with the G229D mutation (Figure 6A). In the population of
1D fibers, both significant QT prolongation and QT shortening
can be observed (Figure 6B). 36 IKs-HET fibers showed QT
prolongation compared to the corresponding IKs-WT fibers. In
the QT prolongation fibers, the AP upstroke was delayed at the
end of the IKs-HET fiber (Figure 6C). In these cases, the QRS
complex was wider, leading to a longer QT interval (Figure 6C,
insert). 18 fibers developed depolarization abnormalities under
IKs-HET, which meant no successful depolarization at the
end of the fibers (Figure 6D), and the QT interval was also
significantly affected (Figure 6D, insert). Similar results were
obtained using transmural fibers (Supplementary Figure S9).
By comparing the parameters of the different groups of fibers,
we found that the conductances of INa, ICaL, IKr, IKs, IK1,
INaCa were significantly different. In both QT prolongation
and depolarization abnormalities, the baseline INa was weak
(Figure 6E). Models exhibiting depolarization abnormalities also
tended to have weak baseline ICaL, IK1, INaCa and relatively
strong IKs, which explained the danger of G229D mutation
presence in their conduction (Figure 6E). The fibers showing QT
prolongation had the strongest baseline IKr, which was consistent
with the results from the cellular simulations.
In silico Simulations Predict That
KCNQ1-G229D Is Capable of Promoting
SN Dysfunction by Perturbing Diastolic
Depolarization
Sinus node dysfunction and bradycardia has been reported for
carriers of different KCNQ1 gain-of-function mutations [S140G
(Chen et al., 2003), V141M (Hong et al., 2005), R231C (Henrion
et al., 2012), V241F (Ki et al., 2014), and F279I (Moreno et al.,
2015)]. Even though SN dysfunction has not been associated
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FIGURE 5 | KCNQ1-G229D can lead to ventricular APD prolongation by altering the interplay between IKr and IKs. Effects of KCNQ1-G229D mutation (IKs-HET) on
IKr and IKs in representative models displaying (A) APD prolongation and (B) APD shortening, at CL = 1,000 ms. The arrows indicate the change of current
magnitude after introducing G229D. In (A), the decrease of IKr is more significant than the increase of IKs, while in (B) the opposite occurs.
with KCNQ1-G229D (Hasegawa et al., 2014) or in the mutation
carriers reported here, the effects of V141M on channel gating
(Hong et al., 2005) are similar to those induced by the G229D
mutation [this study and (Hasegawa et al., 2014)]. Therefore,
we investigated whether the G229D mutation can cause SN
dysfunction in populations of sino-atrial node cells. In a recently
published human SN model (Fabbri et al., 2017), the normal SN
model had a stable heart rate (HR) around 73.7 beats per minute
(bpm) (Figure 7A). Starting from the same initial condition,
when introduced IKs-HET produced an increasingly stronger
IKs and slower HR, and the sinus rhythm was terminated after
625 s (Figure 7A). Plugging the IKs-HET model developed by
(Hasegawa et al., 2014) into the simulation was confirmatory,
as this model also led to sinus rhythm termination after 135 s
(Supplementary Figure S10).
Sinus node activity was related to the interplay between the
calcium subsystem and membrane potential in agreement with
(Lakatta et al., 2010). For successful spontaneous SN activation, a
positive feedback loop between subsarcolemmal calcium (Casub)
and Vm was needed for the diastolic depolarization. ICaL
and INaCa provided the biggest depolarization current during
the upstroke phase, and the net current excluding ICaL and
INaCa was always positive (Supplementary Figures S11, S12).
The activation of INaCa was regulated by Casub, and during
diastolic depolarization, ICaL provided the biggest contribution
for the initial accumulation of Casub (Supplementary Figure
S13). During normal diastolic depolarization, the total net
current was inward, leading to very slow/limited activation
of ICaL, accumulation of Casub and enhancement of INaCa
(Figure 7B, left columns). At the end of diastolic depolarization,
the augmentation of INaCa was strong enough to result in a
significant increase in Vm that further activated ICaL, promoting
faster depolarization in a positive feedback manner to initiate the
upstroke phase (Figure 7B, left columns).
In the SN cell model IKs-HET produced a much stronger
repolarization current to counteract the diastolic depolarization
process. At the time of diastolic depolarization interruption
(time = 628.5 s), IKs became so strong that the overall total
current became outward. The membrane potential then started
to decrease, along with the slow decay of ICaL, Casub, and
INaCa activity (Figure 7B, right columns). Consequently, positive
feedback during the depolarization phase was interrupted.
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FIGURE 6 | KCNQ1-G229D can impair conduction safety by counteracting action potential upstroke. (A) Pseudo-ECG of the original ORd human homogeneous
epicardial 1D fiber. (B) Longer and shorter QT intervals are possible in the presence of the G229D mutation (IKs-HET) in Pseudo-ECGs of the population of human
epicardial 1D fiber. (C) APs of a fiber that showed slower conduction in the presence of the G229D mutation, with the corresponding pseudo-ECG as an insert.
(D) APs of a fiber that showed a depolarization abnormality in the presence of the G229D mutation, with the corresponding pseudo-ECG as an insert. (C,D) There
are 100 nodes in the whole fiber, and Node 20 (dashed lines) and Node 80 (solid lines) are at sites near the beginning and the end of the fiber. (E) Comparisons of
ionic current conductances between the fibers that showed shorter QT, longer QT and depolarization abnormalities in the presence of G229D (∗∗∗P < 0.001,
∗∗P < 0.01, ∗P < 0.05) (Wilcoxon rank-sum test). Black points indicate extreme values that lie more than 1.5 times the interquartile range away from the top (the
75th percentile) or bottom (the 25th percentile) of the box.
To understand why the carriers of KCNQ1-G229D described
in our study and those reported by (Hasegawa et al., 2014) do
not present with bradycardia, we used a population of human
SN models to explore the effects of heterogeneity in ion channel
expression. In the 1,046 human SN cell models, 168 models are
robust to IKs-HET, 153 models became bradycardic, and the
rest (725 models) displayed pacemaking failure. By comparing
the parameters, we identified differences in IKs, ICaL, INaCa,
INaK, and IKr conductances between models displaying different
phenotypes (Figure 7C). As expected, the Pacemaking failure
group had the highest level of IKs-HET. A stronger ICaL in
the Robust and Bradycardia groups can counteract the changes
caused by IKs-HET and enable safer spontaneous activation. In
the Robust group, a stronger inward INaCa and a weaker outward
INaK contributed to maintaining negative total current during
diastolic depolarization. In addition, a stronger IKr in Robust and
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FIGURE 7 | KCNQ1-G229D can cause sinus node dysfunction. (A) IKs-HET
presence results in a loss of sinus rhythm. (B) Comparison between the last
spontaneous activated beat and the failing process under IKs-HET. The red
circles in the right columns indicate the time = 628.5 s when diastolic
depolarization was interrupted, and membrane potential started to decrease.
(C) Parameter comparison between Robust, Bradycardia, and Pacemaking
failure groups under IKs-HET (∗∗∗P < 0.001, ∗∗P < 0.01, ∗P < 0.05)
(Wilcoxon rank-sum test). Black points indicate extreme values that lie more
than 1.5 times the interquartile range away from the top (the 75th percentile)
or bottom (the 25th percentile) of the box.
Bradycardia groups can counteract the effect of high level ICaL,
preventing excessive APD prolongation (Figure 7C).
DISCUSSION
In this present study, we investigate the complex phenotypic
implications of a gain-of-function mutation in IKs (KCNQ1-
G229D) through a combination of computational modeling
and simulation and patch clamp experimental characterization,
as well as clinical presentation. We describe members of a
family that carry KCNQ1-G229D and report that this mutation
underlies a complex phenotype characterized by AF, borderline
LQT and sudden death. Our clinical findings correlate well
with those reported by Moreton et al. (2013) and Hasegawa
et al. (2014). We explored the pathogenic role of this mutation
using a combination of in vitro experiments and in silico
simulations in human SN, atrial and ventricular models. In
addition to providing further evidence supporting the role of
G229D in promoting AF as shown in previous studies, we
expand our knowledge of G229D and other gain-of-function
KCNQ1 mutations in additional ways. Firstly, we present the
first mechanistic investigation into why the G229D mutation
(and perhaps other KCNQ1 gain-of function mutations) could
be associated with a borderline LQT phenotype. Secondly, we
demonstrate that the gain-of-function mutation could promote
pro-arrhythmic conduction abnormalities by counteracting the
AP depolarization phase and reducing conduction safety. This
could be a critical mechanism of sudden cardiac death. Thirdly,
we utilize populations of human SN models to provide detailed
mechanistic predictions which highlight that KCNQ1-G229D
could underlie SN dysfunction. Finally, our findings provide
plausible reasons for observed phenotypic variability and insights
for the clinical management of these patients.
A Potential Explanation for G229D
Associated QT Prolongation
The mechanisms underlying the presence of borderline LQT in
G229D carriers [(Moreton et al., 2013; Hasegawa et al., 2014)
and this study] and other KCNQ1 gain-of-function mutations
(particularly S140G) (Chen et al., 2003; Lundby et al., 2007;
Bartos et al., 2011, 2013) are unclear. We used a population
of human ventricular cell models to investigate the complex
interactions between different currents in the presence of G229D.
In addition to APD shortening produced by the standard
ventricular model, a subset of the models in the population
exhibited APD prolongation. We found that APD prolongation
was caused by an interplay between a decrease in IKr activity
and increase in IKs activity at slow pacing. Based on our
simulations, the instantaneous current component produced
by KCNQ1-G229D reduces the magnitude of the AP upstroke
which leads to a smaller peak membrane voltage and a lower
plateau. Consequently, the presence of a lower plateau acts to
decrease the activity of IKr which, in turn, acts to prolong
APD. In our fibers showing QT prolongation at the tissue level,
IKr tended to be stronger, suggesting that the IKr/IKs interplay
mechanism, originally identified in single cells, also holds true at
the tissue level.
KCNQ1-G229D May Induce Defects in
Conduction
The 1D fiber results also indicate that the presence of KCNQ1-
G229D could impair myocardial conduction. Although QRS
widening in fibers was not observed clinically in mutation
carriers, whole ventricle simulations have shown that QRS width
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is more sensitive to the activation pattern in the conduction
system rather than myocardial propagation (Cardone-Noott
et al., 2016). Therefore, local conduction abnormalities in the
myocardium may still be present even with normal QRS width.
Local or regional conduction abnormalities may also occur due
to heterogeneous expression of KCNQ1/G229D throughout the
ventricles (Liu and Antzelevitch, 1995; Viswanathan et al., 1999).
Although the fiber simulations we used do not account for the
full heterogeneity known to span the human ventricles, they
do provide a rough approximation of tissue behavior. Despite
these potential limitations, our findings emphasize that G229D
could enhance regional differences in conduction and this could
contribute to the substrate required for the formation of a
lethal arrhythmia.
In silico Modeling Using Human Models
Provides Explanations for SN and Atrial
Dysfunction
Our human SN model simulations predict that the G229D
mutation is likely to underlie SN dysfunction and that this could
increase the risk of sinus arrest. By examining variations in ionic
current density, our population of SN models may also provide
plausible explanations as to why a dysfunctional SN phenotype
was not seen by Hasegawa et al. (2014) or in the mutation carriers
we report. Based on the mechanisms revealed in this study and
those of Fabbri et al. (2017) and Whittaker et al. (2018), disturbed
SN activity could be a general action of KCNQ1 gain-of-function
mutations that alter channel gating in a similar fashion.
Mechanistically, the G229D mutation has been postulated
to cause AF by promoting atrial APD shortening (Hasegawa
et al., 2014) and two and three-dimensional tissue models
have described that this mutation promotes the sustainment
of re-entrant waves thereby increasing susceptibility to atrial
arrhythmia (Zulfa et al., 2016). In our baseline and population
of models, the G229D mutation results in atrial and ventricular
AP shortening, but the average degree of shortening is less for
ventricular than atrial APs, which agrees with the findings of
Hasegawa et al. (2014) and implies a more prominent effect of
the mutation on the human atria.
Clinical Implications for KCNQ1-G229D
Carriers
KCNQ1-G229D presents in adults largely as AF, and Class I drugs
such as flecainide and quinidine may be prescribed. Based on our
simulation results, KCNQ1-G229D could impair conduction by
counteracting AP upstroke, and class I sodium channel blockers
could exacerbate this. Furthermore, our simulations predict that
this mutation could underlie SN dysfunction which has been
postulated to act as a substrate for the development of AF
(Duhme et al., 2013). Indeed, a trend in disease progression from
bradycardia in to persistent AF has been reported for patients that
carry the KCNQ1 gain-of-function mutation V241F (Ki et al.,
2014). As revealed by our SN simulations, ICaL played a crucial
role in the maintenance of normal sinus rhythm in the presence
of the G229D mutation. Therefore, drugs with class IV calcium
channel blocking actions could unravel bradycardia in G229D
mutation carriers with normal sinus rhythm.
Our simulations showed that QT prolongation was primarily
observed during bradycardia implying that the prevention of
bradycardia to maintain sinus rhythm should be considered
in the management of mutation carriers. The use of drugs
with a negative chronotropic effect, such as beta-blockers,
should therefore be reviewed and device implantation considered
for KCNQ1 gain-of-function mutation carriers that present
with bradycardia.
Another intriguing observation is that some G229D mutation
carriers have died suddenly whilst sleeping [reported in this study
and (Moreton et al., 2013)]. Sudden cardiac arrest during sleep
has also been reported for a carrier of KCNQ1-R231H (Bartos
et al., 2013). Unfortunately, we do not have the necessary clinical
information to establish the precise mechanisms underlying these
deaths. In LQT1, cardiac arrest normally occurs during exercise
and sudden cardiac death during sleep is more a feature of
LQT3 (Schwartz et al., 2001). Therefore, we can propose two
possible mechanisms: sinus arrest without escape rhythms or a
lethal arrhythmia caused by severe QT prolongation. It is worth
noting that sinus arrest, due to SN dysfunction, is an unusual
cause of death and SN disease in the absence of symptoms is
not generally considered prognostically important. In view of
these considerations we suspect that the most likely mechanism
of sudden death in these patients is the promotion of a lethal
arrhythmia by QT prolongation and/or conduction block.
Limitations of the Study
The effects of the G229D mutation on IKs channel function
were modeled in a heterologous expression system. Therefore,
it is possible that the expression and kinetics of the mutant
channel complex could be distinct in cardiomyocytes. We were
limited to this model because: (1) it is not possible to use
mice or rats as a model as these species do not use IKs for
cardiac repolarization in adult life (Nerbonne, 2014). (2) The
generation of transgenic rabbit models of KCNQ1 mutations
(Brunner et al., 2008), would be prohibitively expensive and the
higher heart rate of this species would likely confound modeling
the effects of the mutation on the SN. (3) The current utility
of human induced pluripotent stem derived cardiomyocytes
(hiPSC-CMs) for examining IKs function has been questioned
and this may relate to their relative immaturity (Christ et al.,
2015). We would also like to highlight that although we propose
an explanation for the borderline LQT seen in carriers of
the G229D mutation the observed APD prolongations in the
population of models subset were relatively mild. This could
relate to the potential differences between the function of
the mutant channel complex in the heterologous expression
system versus in cardiomyocytes or alternatively it could imply
that other mechanisms contributing to QT prolongation exist.
In the future, the validation of our in silico predictions in
a physiological system is warranted. hiPSC-CM technology
is rapidly advancing, and we hope that in time we will be
able to use this model to study the effects of the G229D
mutation in human cardiomyocytes that possess adult-like and
chamber/region specific electrophysiological properties.
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CONCLUSION
By using a combined in vitro and in silico approach we have
explored how the KCNQ1 mutation G229D can underlie the
reported phenotype of AF and borderline QT prolongation.
In addition, our modeling results suggest that the G229D
mutation can cause conduction abnormalities, and can underlie
SN dysfunction. Importantly, our results suggest that for G229D
mutation carriers (and perhaps for other KCNQ1 gain-of-
function mutation carriers), the prescription of beta-blockers,
class I sodium channel blockers and compounds with class IV
calcium channel blocking properties should be used with caution.
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